NEW YORK (GenomeWeb News) – A group of Swiss partners today announced a collaboration to develop, use, and promote a flow cytometry data analysis platform.

The deal brings together the SIB Swiss Institute of Bioinformatics, Geneva Bioinformatics (GeneBio), and Quartz Bio to combine SIB's MegaClust analysis platform with Quartz Bio's expertise in clinical data analysis "to provide unprecedented unbiased in-depth analysis of flow cytometry data," the firms said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.